One type of this disease can be treated with Bortezomib, the first proteasome inhibitor approved for therapeutic use.
One type of this disease can be treated with Bortezomib, the first proteasome inhibitor approved for therapeutic use. That type of this disease is often typified by an overexpression of cyclin D1 and is known as the mantle cell variant. One type of this disease causes Pel-Ebstein fevers and is characterised by multinucleate Reed-Sternberg cells. Another type of this disease arises from a translocation of chromosomes 8 and 14, often due to Epstein-Barr virus infection. For 10 points, give this cancer of B or T cells, with variants such as Burkitt's and Hodgkin.
One type of this disease can be treated with Bortezomib, the first proteasome inhibitor approved for therapeutic use.
{Lymphoma} [accept myeloma before ‘cyclin D1’]